Skip to main content
Log in

Platelet phenolsulphotransferase activity, monoamine oxidase activity and peripheral-type benzodiazepine binding in demented patients

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Blood platelet phenolsulphotransferase and monoamine oxidase activities, as well as platelet peripheral-type benzodiazepine binding have been studied in several neuropsychiatric disorders, in order to identify biochemical markers for altered brain functioning. In the present work, we determined platelet phenolsulphotransferase and monoamine oxidase activities in demented patients: they showed significantly higher phenolsulphotransferase and monoamine oxidase activities than controls. A significant positive correlation was found between enzyme activities and severity of illness. In the same subjects, we evaluated platelet peripheral-type benzodiazepine binding: a significant reduction of Bmax values was observed in demented patients, whereas Kd values did not substantially differ between the two subject groups.

These findings are discussed with reference to central nervous system biochemical abnormalities of demented subjects: it may be that in Dementia of Alzheimer type either some central biochemical changes are reflected in certain peripheral tissues (such as platelets), or a systemic derangement occurs together with a cerebral involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Adolfsson R, Gottfries CG, Oreland L, Wiberg A, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27: 1029–1034

    Google Scholar 

  • Alexopoulos GS, Lieberman KW, Young RC (1984) Platelet MAO activity in primary degenerative dementia. Am J Psychiatry 141: 97–99

    Google Scholar 

  • Anholt RR, Pedersen PL, De Souza EB, Snyder SH (1986) The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem 261: 576–586

    Google Scholar 

  • Belendiuk K, Belendiuk GW, Freedman DX, Antel IP (1981) Neurotransmitter abnormalities in patients with motor neuron disease. Arch Neurol 38: 415–417

    Google Scholar 

  • Belmaker RH, Ebbesen K, Ebstein R, Rimon R (1976) Platelet monoamine oxidase in schizophrenia and manic-depressive illness. Br J Psychiatry 129: 227–232

    Google Scholar 

  • Benavides J, Fages D, Carter C, Scatton B (1987) Peripheral-type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Brain Res 421: 167–172

    Google Scholar 

  • Bidder M, Ratzoni G, Weizman A, Blumensohn R, Norymberg M, Tyano S, Gavish M (1990) Platelet benzodiazepine binding in Alzheimer's disease. Biol Psychiatry 28: 641–643

    Google Scholar 

  • Bongioanni P (1987) Platelet as a model in neurological studies: biochemical and clinical features. Arch Psicol Neurol Psichiat 48: 169–192

    Google Scholar 

  • Bongioanni P (1988) Platelets as model in psychiatric studies. N P S 8: 582–618

    Google Scholar 

  • Bongioanni P (1989) Platelet benzodiazepine binding sites. Psychopathologia 7: 125–134

    Google Scholar 

  • Bongioanni P, Dadone F, Donato M (1991a) Human blood platelet as research tool in neuropsychopharmacology. J Neural Transm [Suppl] 33: 65–71

    Google Scholar 

  • Bongioanni P, Rimonsson T, Donato M (1991b) Enhanced platelet monoamine oxidase activity as marker of degeneration in the central nervous system. Eur J Clin Invest 21: 24

    Google Scholar 

  • Bonuccelli U, Nuti A, Del Dotto P, Piccini P, Martini C, Giannaccini G, Lucacchini A, Muratorio A (1991) Platelet peripheral benzodiazepine receptors are decreased in Parkinson's disease. Life Sci 48: 1185–1190

    Google Scholar 

  • Diorio D, Welner SA, Butterworth RF, Meaney MJ, Suranyi-Cadotte BE (1991) Peripheral benzodiazepine binding sites in Alzheimer's disease frontal and temporal cortex. Neurobiol Aging 12: 255–258

    Google Scholar 

  • Elchisak MA (1983) Distribution of free and conjugated dopamine in human caudate nucleus, hypothalamus and kidney. J Neurochem 41: 893–896

    Google Scholar 

  • Foldes A, Meek JL (1973) Rat brain phenolsulphotransferase — partial purification and some properties. Biochim Biophys Acta 327: 365–373

    Google Scholar 

  • Glover V, Lees AJ, Ward C, Stern GM, Sandler M (1983) Platelet phenolsulphotransferase activity in Parkinson's disease. J Neural Transm 57: 95–102

    Google Scholar 

  • Hambley JW, Johnston GAR (1985) Uptake of gamma-aminobutyric acid by human blood platelets: comparison with CNS uptake. Life Sci 36: 2053–2058

    Google Scholar 

  • Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56–62

    Google Scholar 

  • Hughes CP, Berg L, Danziger WL, Cohen LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566–572

    Google Scholar 

  • Johnson GA, Baker CA, Smith RT (1980) Radioenzymatic assay of sulfate conjugates of cathecolamines and dopa in plasma. Life Sci 26: 1591–1598

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275

    Google Scholar 

  • Mangano RM, Schwarcz R (1981) The human platelet as a model for the glutamatergic neuron: platelet uptake of L-glutamate. J Neurochem 36: 1067–1076

    Google Scholar 

  • Mann JJ, Chiu E (1978) Platelet monoamine oxidase activity in Huntington's chorea. J Neurol Neurosurg Psychiatry 41: 809–812

    Google Scholar 

  • Mann JJ, Stanley M, Kaplan RD, Sweeney J, Neophytides A (1983) Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease. J Neurol Neurosurg Psychiatry 46: 905–910

    Google Scholar 

  • McGeer EG, Singh EA, McGeer PL (1988) Peripheral-type benzodiazepine binding in Alzheimer disease. Alzheimer Dis Assoc Disord 2: 331–336

    Google Scholar 

  • Mizuno Y, Suzuki K, Ohta S (1990) Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease. J Neurol Sci 96: 49–57

    Google Scholar 

  • Moingeon P, Dessaux JJ, Fellous R, Alberici GF, Bidart JM, Motté P, Bohuon C (1984) Benzodiazepine receptors on human blood platelets. Life Sci 35: 2003–2009

    Google Scholar 

  • Owen F, Poulter M, Waddington JL, Mashal RD, Crow TJ (1983) [3H]Ro 5-4864 and [3H]flunitrazepan binding in kainate-lesioned rat striatum and in temporal cortex of brains from patients with senile dementia of the Alzheimer type. Brain Res 278: 373–375

    Google Scholar 

  • Parker WD, Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 26: 719–723

    Google Scholar 

  • Pazos A, Cymerman U, Probst A, Palacios JM (1986) “Peripheral” benzodiazepine binding sites in human brain and kidney: autoradiographic studies. Neurosci Lett 66: 147–152

    Google Scholar 

  • Pletscher A (1978) Platelets as models for monoaminergic neurons In: Youdim MBH (ed) Essays in neurochemistry and neuropharmacology, vol 3. John Wiley & Sons, London, pp 49–101

    Google Scholar 

  • Pletscher A (1988) Platelets as models: use and limitations. Experientia 44: 152–155

    Google Scholar 

  • Reichmann H, Florke S, Hebenstreit G, Schrubar H, Riederer P (1993) Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease. J Neurol 240: 377–380

    Google Scholar 

  • Romain Y, Demassieux S, D'Angelo G, Gyger M, Carrière S (1986) Is the platelet phenolsulfotransferase involved in the sulfoconjugation of plasma catecholamines? Can J Physiol Pharmacol 64: 1197–1201

    Google Scholar 

  • Sandler M, Usdin E (1981) Phenolsulphotransferase in mental health research. Macmillan, London

    Google Scholar 

  • Saura J, Luque JM, Cesura AM, Da Prada M, Chan-Palay V, Huber G, Löffler J, Richards JG (1994) Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neurosci 62: 15–30

    Google Scholar 

  • Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson's disease Lancet 1: 1269

    Google Scholar 

  • Sharpless NS, Tyce GM, Thal LJ, Waltz JM, Tabaddor K, Wolfson LI (1981) Conjugated dopamine in human ventricular fluid. In: Sandler M, Usdin E (eds) Phenolsulphotransferase in mental health research. Macmillan, London, pp 164–174

    Google Scholar 

  • Smith RC, Ho BT, Kralik P, Vroulis MSG, Gordon J, Wolf J (1982) Platelet monoamine oxidase in Alzheimer's disease. J Gerontol 37: 572–574

    Google Scholar 

  • Young WF, Laws ER, Sharbrough FW, Weinshilboum R (1985) Human phenolsulphotransferase: correlation of brain and platelet activities. J Neurochem 44: 1131–1137

    Google Scholar 

  • Zeller EA, Boshes B, Arbit J, Bieber M, Blonsky ER, Dolkart M, Huprikar SV (1976) Molecular biology of neurological and psychiatric disorders. I. Effect of parkinsonism, age, sex and L-dopa on platelet monoamine oxidase. J Neural Transm 39: 63–77

    Google Scholar 

  • Zubenko GS, Wusylko M, Boiler F, Teply I (1987) Family study of platelet membrane fluidity in Alzheimer's disease. Science 238: 539–542

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bongioanni, P., Donato, M., Castagna, M. et al. Platelet phenolsulphotransferase activity, monoamine oxidase activity and peripheral-type benzodiazepine binding in demented patients. J. Neural Transmission 103, 491–501 (1996). https://doi.org/10.1007/BF01276422

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01276422

Keywords

Navigation